MRI and Open-Source Python Tool Reveal How Subcutaneous Drug Depots Really Form
An ex vivo porcine skin model combined with MRI and open-source computational analysis quantified subcutaneous drug depots for semaglutide and ...
An ex vivo porcine skin model combined with MRI and open-source computational analysis quantified subcutaneous drug depots for semaglutide and ...
A subject-level analysis of 91 placebo-controlled trials covering nearly 108,000 participants found no increased risk of suicidal ideation or behavior ...
A new review in Cardiovascular Diabetology describes how FDA-approved oral GLP-1 receptor agonists such as semaglutide and orforglipron are expanding ...
A meta-analysis of two phase 3 trials found once-weekly IcoSema reduced body weight by 6.1 kilograms and improved blood pressure ...
A new narrative review argues that GLP-1 receptor agonists should be repositioned as foundational cardio-renal-metabolic protectors, with trial evidence extending ...
An exploratory mouse study found that 28 days of semaglutide exposure significantly increased the osteoblast-covered bone surface without detectable changes ...
A meta-analysis of five phase 3 trials found that incretin-based therapies lowered DXA-measured lean body mass versus comparators, though certainty ...
A new review builds an evidence-tiered framework for predicting GLP-1 therapy response in fatty liver disease using host genotype and ...
Nausea, vomiting, diarrhea and constipation are the price many people pay for the remarkable weight loss and blood sugar control ...
A large real-world cohort study finds that breast cancer patients exposed to GLP-1 receptor agonists had a much lower incidence ...
A Bayesian decision model suggests MASLD follow-up intensity should be calibrated to patient adherence, with aggressive monitoring favored for lifestyle-modification ...
A retrospective cohort of 269 breast cancer patients found that GLP-1 receptor agonists produced significant but markedly attenuated weight loss ...
A systematic review of eight randomized trials concludes that the skeletal effects of GLP-1 receptor agonists in adults with overweight ...
A combined genetic, cellular, and mouse study finds that semaglutide strengthens gemcitabine's antitumor effect by suppressing RRM1 while weakening methotrexate ...
A planned protocol describes three separate open-label pilots assessing feasibility, acceptability, safety, tolerability and alcohol-consumption measures for off-label medications in ...
A large retrospective cohort found that hormone-therapy use was associated with greater, sustained semaglutide weight loss in midlife women, while ...
A new meta-analysis of six randomized controlled trials shows CagriSema significantly lowers HbA1c, body weight, and blood pressure in type ...
A new narrative review finds that GLP-1 receptor agonists like semaglutide and tirzepatide are safe and effective for weight loss ...
A new opinion article argues that inflammation may be the missing link explaining both the potential suicide risk and the ...
A new viewpoint in eClinicalMedicine argues that cardiorenal trials should routinely report absolute risk reduction and number needed to treat ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.